Clinical Trial Update: ZN-c3 + Gemcitabine in Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on the combination of ZN-c3 with gemcitabine for pancreatic cancer, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• ZN-c3

Snippet

Sponsor: Brandon Huffman, MD | Conditions: Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING